Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Guardant Health, Inc. on May 5, 2022, reporting an event that occurred on May 4, 2022. The filing addresses corporate governance changes specifically regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate event and does not contain financial performance data.
Material Changes
The material change reported is the resignation of Dr. Bahija Jallal from the Board of Directors. Her resignation is effective as of the Company's next Annual Meeting of Stockholders, scheduled for June 15, 2022.
Management Commentary and Risks
Dr. Jallal informed the Company that her decision to resign was not the result of any dispute or disagreement with the Company on any matter relating to its operations, policies, or practices. No other risks, contingencies, or unusual items are disclosed in this filing.
Key Facts for Investor Verification
- Dr. Bahija Jallal is resigning as a director effective June 15, 2022.
- The resignation is voluntary and not due to any disagreement with the Company.
- The filing contains no financial data or operational updates beyond the director departure.